Allarity Therapeutics ALLR
NASDAQ ALLR
$0.88 +0.00 (+0.32%)
At close: Oct 20, 2026 · 4:00 PM EDT

Allarity Therapeutics (ALLR) Revenue (2020 - 2026)

Updated

Allarity Therapeutics (ALLR) reported Revenue of $25,000 for Q1 2026.

Analysis

Allarity Therapeutics (ALLR) Revenue (2020 - 2026) Analysis & Trends

For FY2025, Allarity Therapeutics posted Revenue of $320,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 25.31 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 16.99 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.38 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 15.03 Bn
10 Allarity Therapeutics 13.89 Mn -54.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 25,000.00
Dec 31, 2021 -890,000.00
Sep 30, 2021 28,000.00
Jun 30, 2021 -393,000.00
Mar 31, 2021 -87,000.00
Sep 30, 2020 221,000.00
API Access

Allarity Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ALLR&period=max&api_key=YOUR_API_KEY